SUPN logo
SUPN

SUPERNUS PHARMACEUTICALS, INC.

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Earnings

Last reported
March 31, 2026
EPS Beat · +97.7%
EPS estimate
$0.30
EPS actual
$0.60
Revenue est.
Revenue actual